{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:04:36Z","timestamp":1791752676181,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00c3\u00b3n Biom\u00c3\u00a9dica en Red de Salud Mental","doi-asserted-by":"publisher","award":["CB07\/09\/0005-G25"],"award-info":[{"award-number":["CB07\/09\/0005-G25"]}],"id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jad.2014.02.022","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T21:46:24Z","timestamp":1392846384000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Prothrombotic platelet phenotype in major depression: Downregulation by antidepressant treatment"],"prefix":"10.1016","volume":"159","author":[{"given":"Irene","family":"Lopez-Vilchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Serra-Millas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rosa Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Diaz-Ricart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristobal","family":"Gasto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-0381","authenticated-orcid":false,"given":"Gines","family":"Escolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2014.02.022_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1046\/j.1365-2362.1999.00570.x","article-title":"Platelet\u2013collagen interactions: membrane receptors and intracellular signalling pathways","volume":"29","author":"Alberio","year":"1999","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jad.2014.02.022_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.jad.2014.02.022_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4088\/JCP.09r05786blu","article-title":"Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms","volume":"71","author":"Andrade","year":"2010","journal-title":"J Clin. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.022_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/JCP.0b013e3181abdfd7","article-title":"Mean platelet volume in patients with major depression: effect of escitalopram treatment","volume":"29","author":"Ataoglu","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2014.02.022_bib5","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.npp.1301355","article-title":"Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study","volume":"32","author":"Atar","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2014.02.022_bib6","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.3949\/ccjm.77.s3.03","article-title":"The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised","volume":"77","author":"Bigger","year":"2010","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.jad.2014.02.022_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2011.08.013","article-title":"Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs","volume":"136","author":"Bismuth-Evenzal","year":"2012","journal-title":"J Affect. Disord."},{"key":"10.1016\/j.jad.2014.02.022_bib8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bcp.2010.07.035","article-title":"N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor","volume":"80","author":"Bismuth-Evenzal","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jad.2014.02.022_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-3223(03)00111-2","article-title":"Depression, mortality, and medical morbidity in patients with coronary heart disease","volume":"54","author":"Carney","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.022_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2004.04.030","article-title":"Depression as a risk factor for post-MI mortality","volume":"44","author":"Carney","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jad.2014.02.022_bib11","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/j.1538-7836.2005.01274.x","article-title":"Coated-platelets: an emerging component of the procoagulant response","volume":"3","author":"Dale","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jad.2014.02.022_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1742-7843.2006.pto_303.x","article-title":"Antidepressants and risk of upper gastrointestinal bleeding","volume":"98","author":"de Abajo","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2014.02.022_bib13","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2002-10-3027","article-title":"Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270","volume":"101","author":"Ding","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jad.2014.02.022_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1358\/dot.2005.41.11.904727","article-title":"Serotonergic mechanisms: a potential link between affective disorders and cardiovascular risk","volume":"41","author":"Escolar","year":"2005","journal-title":"Drugs Today (Barc.)"},{"key":"10.1016\/j.jad.2014.02.022_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1160\/TH08-12-0810","article-title":"Serotonergic mechanisms enhance platelet-mediated thrombogenicity","volume":"102","author":"Galan","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jad.2014.02.022_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PSY.0000000000000027","article-title":"Association of anxiety disorders and depression with incident heart failure","volume":"76","author":"Garfield","year":"2014","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2014.02.022_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2008.07.011","article-title":"Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice","volume":"593","author":"Gunther","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2014.02.022_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/eurheartj\/ehr368","article-title":"Psychotropic medications and the risk of sudden cardiac death during an acute coronary event","volume":"33","author":"Honkola","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jad.2014.02.022_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2014.02.022_bib20","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1182\/blood-2011-09-336933","article-title":"Transporters in human platelets: physiologic function and impact for pharmacotherapy","volume":"119","author":"Jedlitschky","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jad.2014.02.022_bib21","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood.V91.11.4216","article-title":"Whole blood tissue procoagulant activity is elevated in patients with sickle cell disease","volume":"91","author":"Key","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jad.2014.02.022_bib22","first-page":"1835","article-title":"Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction","volume":"183","author":"Labos","year":"2011","journal-title":"C.M.A.J"},{"key":"10.1016\/j.jad.2014.02.022_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/STROKEAHA.113.003741","article-title":"Prospective study of anxiety and incident stroke","volume":"45","author":"Lambiase","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jad.2014.02.022_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.297.4.367","article-title":"Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial","volume":"297","author":"Lesperance","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2014.02.022_bib25","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.108.190769","volume":"118","author":"Lichtman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2014.02.022_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0029-1222611","article-title":"Mental depression and cardiovascular disease: a multifaceted, bidirectional association","volume":"35","author":"Lippi","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jad.2014.02.022_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cvr\/cvp205","article-title":"Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake","volume":"84","author":"Lopez-Vilchez","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jad.2014.02.022_bib28","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1016\/j.thromres.2012.10.003","article-title":"Platelet-associated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro","volume":"130","author":"Lopez-Vilchez","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jad.2014.02.022_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.pnpbp.2010.06.008","article-title":"Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.022_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH03-05-0330","article-title":"The influence of selective serotonin reuptake inhibitors on human platelet serotonin","volume":"91","author":"Maurer-Spurej","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jad.2014.02.022_bib31","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00127-011-0421-5","article-title":"Co-morbid cardiovascular disease and depression: sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study","volume":"47","author":"O\u05f3Neil","year":"2012","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.jad.2014.02.022_bib32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/01.RES.0000251742.71301.16","article-title":"Activation of platelet function through G protein-coupled receptors","volume":"99","author":"Offermanns","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.jad.2014.02.022_bib33","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.bbamem.2008.04.007","article-title":"Psychotropic drugs interfere with the tight coupling of polyphosphoinositide cycle metabolites in human platelets: a result of receptor-independent drug intercalation in the plasma membrane?","volume":"1778","author":"Oruch","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jad.2014.02.022_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.npp.1300092","article-title":"Serotonin transporter: A potential substrate in the biology of suicide","volume":"28","author":"Purselle","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2014.02.022_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0022-3956(88)90024-6","article-title":"A new validation of the Hamilton Rating Scale for Depression","volume":"22","author":"Ramos-Brieva","year":"1988","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2014.02.022_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-3223(93)90276-J","article-title":"Interaction between antidepressants and phosphoinositide signal transduction system in human platelets","volume":"33","author":"Rehavi","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.022_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2009.06.036","article-title":"Exposure to tricyclic antidepressants is associated with an increased risk of incident CHD events in a population-based study","volume":"145","author":"Rosenberg","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jad.2014.02.022_bib38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9149(01)02236-6","article-title":"Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes","volume":"89","author":"Shimbo","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jad.2014.02.022_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1160\/TH07-10-0630","article-title":"Identification of 5-HT3 receptors on human platelets: increased surface immunoreactivity after activation with adenosine diphosphate (ADP) and thrombin receptor-activating peptide (TRAP)","volume":"99","author":"Stratz","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jad.2014.02.022_bib40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archpsyc.62.7.792","article-title":"Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction","volume":"62","author":"Taylor","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2014.02.022_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.109.881987","article-title":"Is it time to treat depression in patients with cardiovascular disease?","volume":"120","author":"Whang","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jad.2014.02.022_bib42","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jacc.2008.10.060","article-title":"Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses\u05f3 Health Study","volume":"53","author":"Whang","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jad.2014.02.022_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2005.10.075","article-title":"Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors","volume":"1067","author":"Yamauchi","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2014.02.022_bib44","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.yjmcc.2012.02.004","article-title":"Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin","volume":"52","author":"Ziu","year":"2012","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032714000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032714000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:12:42Z","timestamp":1759021962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032714000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":44,"alternative-id":["S0165032714000603"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2014.02.022","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prothrombotic platelet phenotype in major depression: Downregulation by antidepressant treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2014.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}